2020 ISCHEMIA TRIAL M Initial Invasive or Conservative Strategy for Stable Coronary Disease multicenter, parallel, randomized controlled trial Objective: Tto determine the effect of adding cardiac catheterization (hereafter, angiography) and revascularization when feasible to medical therapy in patients with stable coronary disease and moderate or severe ischemia 5,179 Patients Inclusion criteria: Patients >20 years of […]
Tag: cardiac cath
UNIVERSAL Trial Summary: US-Guided Femoral Access
2022 UNIVERSAL TRIAL Routine ultrasonography guidance for femoral vascular access for cardiac procedures multicenter, randomized controlled trial Objective: To determine whether routinely using ultrasonography guidance for femoral arterial access for coronary angiography/intervention reduces bleeding or vascular complications 621 Patients Inclusion criteria: Patients ≥18 years with referral for coronary angiography or percutaneous coronary intervention with planned […]
AIDA Trial Summary: Bioabsorbable Scaffolds for Routine PCI
2017 AIDA TRIAL Bioresorbable scaffolds versus metallic stents in routine PCI Prospective, multi-center, single-blind, randomized controlled trial M Objective: To assess if bioresorbable scaffolds superior to standard drug-eluting stents (DES) with regard to target-vessel failure in patients with stable or unstable CAD undergoing PCI 1,845 Inclusion criteria: patients with stable or unstable patients coronary artery […]
NAPLES III Trial Summary: Bivalirudin in Patients with High Risk of Bleeding Undergoing LHC
2015 NAPLES III TRIAL Randomized comparison of bivalirudin versus unfractionated heparin in patients at increased risk of bleeding undergoing transfemoral elective coronary stenting double-blind, single-center, randomized controlled trial Objective: To assess the safety & the efficacy of bivalirudin compared with unfractionated heparin (UFH) alone in the subset of patients at increased risk of bleeding undergoing […]